Eisai Co Ltd (4523):企業の財務・戦略的SWOT分析

◆英語タイトル:Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2724
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Eisai Co Ltd (4523) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Eisai Co Ltd (Eisai) is a pharmaceutical company that undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer’s agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others. Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK; overseas sales offices in the US, Germany, France, China and South Korea. Eisai is headquartered in Tokyo, Japan.

Eisai Co Ltd Key Recent Developments

Jul 27,2018: AAIC 2018 introduces first clinical trial showing intensive blood pressure therapy reduces new cases of mild cognition and dementia
Jul 19,2018: PhoenixBio provides results from studies using PXB-Mouse and PXB-cells being presented at ISSX 2018
Jul 18,2018: Eisai supports relief efforts for flooding in western Japan
Jul 04,2018: Eisai Listed For 17th Consecutive Year In FTSE4GOOD Index Series, An Index For Socially Responsible Investment
Jun 13,2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Eisai Co Ltd – Key Facts 6
Eisai Co Ltd – Key Employees 7
Eisai Co Ltd – Key Employee Biographies 10
Eisai Co Ltd – Major Products and Services 11
Eisai Co Ltd – History 13
Eisai Co Ltd – Company Statement 21
Eisai Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 25
Section 2 – Company Analysis 26
Company Overview 26
Eisai Co Ltd – Business Description 27
Product Category: Neurology Products 27
Overview 27
Performance 27
Product Category: Oncology Products 27
Overview 27
Performance 27
Product Category: Others 28
Performance 28
Product Category: Americas Pharmaceutical Business 28
Overview 28
Performance 28
Product Category: Asia and Latin America Pharmaceutical Business 28
Overview 28
Performance 28
Product Category: China Pharmaceutical Business 29
Overview 29
Performance 29
Product Category: EMEA Pharmaceutical Business 29
Overview 29
Performance 29
Product Category: Japan Pharmaceutical Business 29
Overview 29
Performance 29
Product Category: Other Business 29
Overview 29
Performance 30
R&D Overview 30
Eisai Co Ltd – Corporate Strategy 31
Eisai Co Ltd – SWOT Analysis 32
SWOT Analysis – Overview 32
Eisai Co Ltd – Strengths 32
Eisai Co Ltd – Weaknesses 33
Eisai Co Ltd – Opportunities 34
Eisai Co Ltd – Threats 35
Eisai Co Ltd – Key Competitors 36
Section 3 – Company Financial Ratios 37
Financial Ratios – Capital Market Ratios 37
Financial Ratios – Annual Ratios 38
Performance Chart 41
Financial Performance 41
Financial Ratios – Interim Ratios 42
Financial Ratios – Ratio Charts 43
Section 4 – Company’s Lifesciences Financial Deals and Alliances 44
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 45
Eisai Co Ltd, Recent Deals Summary 46
Section 5 – Company’s Recent Developments 47
Jul 27, 2018: AAIC 2018 introduces first clinical trial showing intensive blood pressure therapy reduces new cases of mild cognition and dementia 47
Jul 19, 2018: PhoenixBio provides results from studies using PXB-Mouse and PXB-cells being presented at ISSX 2018 51
Jul 18, 2018: Eisai supports relief efforts for flooding in western Japan 52
Jul 04, 2018: Eisai Listed For 17th Consecutive Year In FTSE4GOOD Index Series, An Index For Socially Responsible Investment 53
Jun 13, 2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States 54
Jun 13, 2018: Eisai To Establish New Research Facility “Eisai Center For Genetics Guided Dementia Discovery” In Cambridge, Massachusetts In The United States 55
Jun 13, 2018: Industry-Academia-Government Joint Development Agreement Concerning Nucleic Acid Drug Discovery Research Using Novel Nucleic Acid Synthesis And Delivery Technologies Concluded 56
Feb 26, 2018: Launch of Dementia Support Insurance to Provide for Dementia in Japan 57
Feb 20, 2018: EISAI Certified In 2018 As Outstanding Health And Productivity Management Organization (WHITE 500) 58
Feb 20, 2018: EISAI Certified In 2018 As Outstanding Health And Productivity Management Organization (WHITE 500) 59
Section 6 – Appendix 60
Methodology 60
Ratio Definitions 60
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Eisai Co Ltd, Key Facts 6
Eisai Co Ltd, Key Employees 7
Eisai Co Ltd, Key Employee Biographies 10
Eisai Co Ltd, Major Products and Services 11
Eisai Co Ltd, History 13
Eisai Co Ltd, Subsidiaries 22
Eisai Co Ltd, Joint Venture 25
Eisai Co Ltd, Key Competitors 36
Eisai Co Ltd, Ratios based on current share price 37
Eisai Co Ltd, Annual Ratios 38
Eisai Co Ltd, Annual Ratios (Cont...1) 39
Eisai Co Ltd, Annual Ratios (Cont...2) 40
Eisai Co Ltd, Interim Ratios 42
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 45
Eisai Co Ltd, Recent Deals Summary 46
Currency Codes 60
Capital Market Ratios 60
Equity Ratios 61
Profitability Ratios 61
Cost Ratios 62
Liquidity Ratios 62
Leverage Ratios 63
Efficiency Ratios 63

List of Figures
Eisai Co Ltd, Performance Chart (2014 - 2018) 41
Eisai Co Ltd, Ratio Charts 43
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 44
Eisai Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 45

★海外企業調査レポート[Eisai Co Ltd (4523):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JSP Corp (7942):企業の財務・戦略的SWOT分析
    JSP Corp (7942) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Engepack Embalagens Sa:企業の戦略・SWOT・財務分析
    Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Southern Company Gas:企業の戦略的SWOT分析
    Southern Company Gas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tyser & Co Limited:企業の戦略的SWOT分析
    Tyser & Co Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務分析
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Cajun Industries, LLC:企業の戦略的SWOT分析
    Cajun Industries, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Crown Castle International Corp (CCI):企業の財務・戦略的SWOT分析
    Crown Castle International Corp (CCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • ResMed Inc. (RMD)-医療機器分野:企業M&A・提携分析
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Xcel Energy Inc (XEL)-エネルギー分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Philips Healthcare-医療機器分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • RPS Group Plc (RPS):企業の財務・戦略的SWOT分析
    RPS Group Plc (RPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Icici Bank Ltd
    Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Icici Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Robert Walters Plc (RWA):企業の財務・戦略的SWOT分析
    Summary Robert Walters Plc (Robert Walters) is a recruitment and consultancy service provider. The company offers placements of professionals on permanent, contract and interim positions. It provides recruitment services for accountancy and finance, banking and financial services, executive search, …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆